Summary:

In this presentation, Dr. Stanley Qi presents cutting-edge CRISPR-based technologies that enable precise, non-DNA-editing control of gene expression. He shares how these tools uncover enhancer interactions driving cancer and how they're used to engineer more effective, long-lasting CAR T cells.

Topics to be covered:

• Synergistic enhancer interactions and their role in oncogene regulation and cancer relapse prediction
• Multiplexed RNA targeting in T cells using the MEGA CRISPR-Cas13 platform
• Development of non-DNA-editing CRISPR tools for safer gene and cell therapy applications

Speakers:

Lei (Stanley) Qi, PhD